FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Cecilia Gotti

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Co-author Network

Publications

TOP 3
Mariaelvina Sala; Fabio Sparatore; Bruno Tasso; Charles R Wageman; Michele Zoli; Daniela Braida; Francesco Clementi; Francesca Fasoli; Sergio Fucile; Sharon R Grady; Barbara Loi; Irene Manfredi; Michael J Marks; Luca Pucci; Cecilia Gotti
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
Clelia Dallanoce; Cecilia Gotti; Carlo Matera; Luca Pucci; Luca Rizzi; Marco De Amici; Francesco Clementi; Carlo De Micheli
The enantiomers of epiboxidine and of two related analogs: synthesis and estimation of their binding affinity at α4β2 and α7 neuronal nicotinic acetylcholine receptors.
Clelia Dallanoce; Marco De Amici; Francesco Clementi; Fabio Frigerio; Sergio Fucile; Cecilia Gotti; Giovanni Grazioso; Carlo Matera; Francesco Pistillo; Luca Pucci; Giacomo Luca Visconti; Carlo De Micheli
New spirocyclic Δ²-isoxazoline derivatives related to selective agonists of α7 neuronal nicotinic acetylcholine receptors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Cecilia Gotti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mariaelvina Sala; Fabio Sparatore; Bruno Tasso; Charles R Wageman; Michele Zoli; Daniela Braida; Francesco Clementi; Francesca Fasoli; Sergio Fucile; Sharon R Grady; Barbara Loi; Irene Manfredi; Michael J Marks; Luca Pucci; Cecilia Gotti
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
British journal of pharmacology 2013;168(4):835-49.
2012: Clelia Dallanoce; Cecilia Gotti; Carlo Matera; Luca Pucci; Luca Rizzi; Marco De Amici; Francesco Clementi; Carlo De Micheli
The enantiomers of epiboxidine and of two related analogs: synthesis and estimation of their binding affinity at α4β2 and α7 neuronal nicotinic acetylcholine receptors.
Chirality 2012;24(7):543-51.
2011: Clelia Dallanoce; Marco De Amici; Francesco Clementi; Fabio Frigerio; Sergio Fucile; Cecilia Gotti; Giovanni Grazioso; Carlo Matera; Francesco Pistillo; Luca Pucci; Giacomo Luca Visconti; Carlo De Micheli
New spirocyclic Δ²-isoxazoline derivatives related to selective agonists of α7 neuronal nicotinic acetylcholine receptors.
European journal of medicinal chemistry 2011;46(12):5790-9.
2011: Cristiano Bolchi; Laura Fumagalli; Cecilia Gotti; Francesco Pistillo; Luca Pucci; Ermanno Valoti; Giulio Vistoli; Matteo Binda; Marco Pallavicini
Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potent α4β2- and α6β2-nicotinic acetylcholine receptor partial agonist.
Journal of medicinal chemistry 2011;54(21):7588-601.
2011: Luca Pucci; Luca Rizzi; Giovanni Grazioso; Renato Longhi; Daniel Bertrand; Sonia Bertrand; Francesco Clementi; Clelia Dallanoce; Marco De Amici; Carlo De Micheli; Cecilia Gotti
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(11):3775-89.
2011: Clelia Dallanoce; Pietro Magrone; Carlo Matera; Fabio Frigerio; Giovanni Grazioso; Marco De Amici; Sergio Fucile; Vanessa Piccari; Karla Frydenvang; Luca Pucci; Cecilia Gotti; Francesco Clementi; Carlo De Micheli
Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors.
ChemMedChem 2011;6(5):889-903.
2011: Anna Maria Capelli; Laura Castelletti; Yu Hua Chen; Harjeet Van der Keyl; Luca Pucci; Beatrice Oliosi; Cristian Salvagno; Barbara Bertani; Cecilia Gotti; Andrew Powell; Manolo Mugnaini
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists.
British journal of pharmacology 2011;163(2):313-29.
2011: Silvia Di Angelantonio; M Egle De Stefano; Alessio Piccioni; Loredana Lombardi; Cecilia Gotti; Paola Paggi
Lack of dystrophin functionally affects α3β2/β4-nicotinic acethylcholine receptors in sympathetic neurons of dystrophic mdx mice.
Neurobiology of disease 2011;41(2):528-37.
2011: Roberta Benfante; Ruth Adele Antonini; Maria De Pizzol; Cecilia Gotti; Francesco Clementi; Massimo Locati; Diego Fornasari
Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS.
Journal of neuroimmunology 2011;230(1-2):74-84.
2010: Clelia Dallanoce; Pietro Magrone; Carlo Matera; Leonardo Lo Presti; Marco De Amici; Loredana Riganti; Francesco Clementi; Cecilia Gotti; Carlo De Micheli
Synthesis of novel chiral Δ2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.
European journal of medicinal chemistry 2010;45(12):5594-601.
2010: Milena Moretti; Manolo Mugnaini; Michela Tessari; Michele Zoli; Annalisa Gaimarri; Irene Manfredi; Francesco Pistillo; Francesco Clementi; Cecilia Gotti
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes.
Molecular pharmacology 2010;78(2):287-96.
2010: Clelia Dallanoce; Fabio Frigerio; Giuliana Martelli; Giovanni Grazioso; Carlo Matera; Diego Yuri Pomè; Luca Pucci; Francesco Clementi; Cecilia Gotti; Marco De Amici
Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes.
Bioorganic & medicinal chemistry 2010;18(12):4498-508.
2010: Cecilia Gotti; Stefania Guiducci; Vincenzo Tedesco; Silvia Corbioli; Lara Zanetti; Milena Moretti; Alessio Zanardi; Roberto Rimondini; Manolo Mugnaini; Francesco Clementi; Christian Chiamulera; Michele Zoli
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(15):5311-25.
2009: Giovanni Grazioso; Diego Yuri Pomè; Carlo Matera; Fabio Frigerio; Luca Pucci; Cecilia Gotti; Clelia Dallanoce; Marco De Amici
Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies.
Bioorganic & medicinal chemistry letters 2009;19(22):6353-7.
2009: Cecilia Gotti; Francesco Clementi; Alice Fornari; Annalisa Gaimarri; Stefania Guiducci; Irene Manfredi; Milena Moretti; Patrizia Pedrazzi; Luca Pucci; Michele Zoli
Structural and functional diversity of native brain neuronal nicotinic receptors.
Biochemical pharmacology 2009;78(7):703-11.
2009: Bruno Tasso; Caterina Canu-Boido; Emanuela Terranova; Cecilia Gotti; Loredana Riganti; Francesco Clementi; Roberto Artali; Gabriella Bombieri; Fiorella Meneghetti; Fabio Sparatore
Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
Journal of medicinal chemistry 2009;52(14):4345-57.
2009: Clelia Dallanoce; Pietro Magrone; Paola Bazza; Giovanni Grazioso; Luca Rizzi; Loredana Riganti; Cecilia Gotti; Francesco Clementi; Karla Frydenvang; Marco De Amici
New analogues of epiboxidine incorporating the 4,5-dihydroisoxazole nucleus: synthesis, binding affinity at neuronal nicotinic acetylcholine receptors, and molecular modeling investigations.
Chemistry & biodiversity 2009;6(2):244-59.
2009: Marco Pallavicini; Cristiano Bolchi; Matteo Binda; antonio Cilia; Francesco Clementi; Rossana Ferrara; Laura Fumagalli; Cecilia Gotti; Milena Moretti; Alessandro Pedretti; Giulio Vistoli; Ermanno Valoti
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity.
Bioorganic & medicinal chemistry letters 2009;19(3):854-9.
2008: Luca Rizzi; Clelia Dallanoce; Carlo Matera; Pietro Magrone; Luca Pucci; Cecilia Gotti; Francesco Clementi; Marco De Amici
Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.
Bioorganic & medicinal chemistry letters 2008;18(16):4651-4.
2008: Cecilia Gotti; Milena Moretti; Natalie M Meinerz; Francesco Clementi; Annalisa Gaimarri; Allan C Collins; Michael J Marks
Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
Molecular pharmacology 2008;73(6):1796-807.
2007: Cecilia Gotti; Milena Moretti; Annalisa Gaimarri; Alessio Zanardi; Francesco Clementi; Michele Zoli
Heterogeneity and complexity of native brain nicotinic receptors.
Biochemical pharmacology 2007;74(8):1102-11.
2007: Annalisa Gaimarri; Milena Moretti; Loredana Riganti; Alessio Zanardi; Francesco Clementi; Cecilia Gotti
Regulation of neuronal nicotinic receptor traffic and expression.
Brain research reviews 2007;55(1):134-43.
2006: Marco Pallavicini; Barbara Moroni; Cristiano Bolchi; antonio Cilia; Francesco Clementi; Laura Fumagalli; Cecilia Gotti; Fiorella Meneghetti; Loredana Riganti; Giulio Vistoli; Ermanno Valoti
Synthesis and alpha4beta2 nicotinic affinity of unichiral 5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes.
Bioorganic & medicinal chemistry letters 2006;16(21):5610-5.
2006: Cecilia Gotti; Michele Zoli; Francesco Clementi
Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
Trends in pharmacological sciences 2006;27(9):482-91.
2006: Cecilia Gotti; Milena Moretti; Iwo Jerzy Bohr; Iryna Ziabreva; Silvia Vailati; Renato Longhi; Loredana Riganti; Annalisa Gaimarri; Ian G McKeith; Robert H Perry; Dag Aarsland; Jan Petter Larsen; Emanuele Sher; Ruth Beattie; Francesco Clementi; Jennifer A Court
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
Neurobiology of disease 2006;23(2):481-9.
2006: Ruth Adele Antonini; Roberta Benfante; Cecilia Gotti; Milena Moretti; Niels Kuster; Juergen Schuderer; Francesco Clementi; Diego Fornasari
Extremely low-frequency electromagnetic field (ELF-EMF) does not affect the expression of alpha3, alpha5 and alpha7 nicotinic receptor subunit genes in SH-SY5Y neuroblastoma cell line.
Toxicology letters 2006;164(3):268-77.
2006: Cecilia Gotti; Loredana Riganti; Silvia Vailati; Francesco Clementi
Brain neuronal nicotinic receptors as new targets for drug discovery.
Current pharmaceutical design 2006;12(4):407-28.
2005: Loredana Riganti; Cosetta Matteoni; Silvia Di Angelantonio; Andrea Nistri; Annalisa Gaimarri; Fabio Sparatore; Caterina Canu-Boido; Francesco Clementi; Cecilia Gotti
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
British journal of pharmacology 2005;146(8):1096-109.
2005: Cecilia Gotti; Milena Moretti; Alessio Zanardi; Annalisa Gaimarri; Nicolas Champtiaux; Jean-Pierre Changeux; Paul Whiteaker; Michael J Marks; Francesco Clementi; Michele Zoli
Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferents.
Molecular pharmacology 2005;68(4):1162-71.
2005: Cecilia Gotti; Milena Moretti; Francesco Clementi; Loredana Riganti; J Michael McIntosh; Allan C Collins; Michael J Marks; Paul Whiteaker
Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
Molecular pharmacology 2005;67(6):2007-15.
2005: Maryka Quik; Silvia Vailati; Tanuja Bordia; Jennifer M Kulak; Hong Fan; J Michael McIntosh; Francesco Clementi; Cecilia Gotti
Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
Molecular pharmacology 2005;67(1):32-41.
2004: Marco Pallavicini; Barbara Moroni; Cristiano Bolchi; Francesco Clementi; Laura Fumagalli; Cecilia Gotti; Silvia Vailati; Ermanno Valoti; Luigi Villa
Synthesis and alpha4beta2 nicotinic affinity of 2-pyrrolidinylmethoxyimines and prolinal oxime ethers.
Bioorganic & medicinal chemistry letters 2004;14(23):5827-30.
2004: Cecilia Gotti; Francesco Clementi
Neuronal nicotinic receptors: from structure to pathology.
Progress in neurobiology 2004;74(6):363-96.
2004: Chantal J G M Smulders; Regina G D M Van Kleef; Arjan de Groot; Cecilia Gotti; Henk P M Vijverberg
A noncompetitive, sequential mechanism for inhibition of rat alpha4beta2 neuronal nicotinic acetylcholine receptors by carbamate pesticides.
Toxicological sciences : an official journal of the Society of Toxicology 2004;82(1):219-27.
2004: Milena Moretti; Silvia Vailati; Michele Zoli; Giordano Lippi; Loredana Riganti; Renato Longhi; Alessandro Viegi; Francesco Clementi; Cecilia Gotti
Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience.
Molecular pharmacology 2004;66(1):85-96.
2004: Arianna Del Signore; Cecilia Gotti; Angela Rizzo; Milena Moretti; Paola Paggi
Nicotinic acetylcholine receptor subtypes in the rat sympathetic ganglion: pharmacological characterization, subcellular distribution and effect of pre- and postganglionic nerve crush.
Journal of neuropathology and experimental neurology 2004;63(2):138-50.
2003: Nicolas Champtiaux; Cecilia Gotti; Matilde Cordero-Erausquin; Denis Joseph Paul David; Cédric Przybylski; Clément Léna; Francesco Clementi; Milena Moretti; Francesco Mattia Rossi; Nicolas Le Novère; J Michael McIntosh; Alain M Gardier; Jean-Pierre Changeux
Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(21):7820-9.
2003: Eric Carbonnelle; Fabio Sparatore; Caterina Canu-Boido; Cristian Salvagno; Barbara Baldani-Guerra; Georg Terstappen; Ruud Zwart; Henk P M Vijverberg; Francesco Clementi; Cecilia Gotti
Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
European journal of pharmacology 2003;471(2):85-96.
2003: Silvia Vailati; Milena Moretti; Renato Longhi; G Enrico Rovati; Francesco Clementi; Cecilia Gotti
Developmental expression of heteromeric nicotinic receptor subtypes in chick retina.
Molecular pharmacology 2003;63(6):1329-37.
2002: Carmen Martin-Ruiz; S Lawrence; Margaret A Piggott; Alexander Kuryatov; Jon Lindstrom; Cecilia Gotti; Mark Cookson; Robert H Perry; Evelyn Jaros; Elaine K Perry; Jennifer A Court
Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression.
Neuroscience letters 2002;335(2):134-8.
2002: Michele Zoli; Milena Moretti; Alessio Zanardi; J Michael McIntosh; Francesco Clementi; Cecilia Gotti
Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(20):8785-9.
2002: Arianna Del Signore; Cecilia Gotti; M Egle De Stefano; Milena Moretti; Paola Paggi
Dystrophin stabilizes alpha 3- but not alpha 7-containing nicotinic acetylcholine receptor subtypes at the postsynaptic apparatus in the mouse superior cervical ganglion.
Neurobiology of disease 2002;10(1):54-66.
2002: A Graham; Jennifer A Court; Carmen Martin-Ruiz; Evelyn Jaros; Robert H Perry; Stephen G Volsen; S Bose; N Evans; Paul Ince; Alexander Kuryatov; Jon Lindstrom; Cecilia Gotti; Elaine K Perry
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum.
Neuroscience 2002;113(3):493-507.
2001: B Barabino; Silvia Vailati; Milena Moretti; J Michael McIntosh; Renato Longhi; Francesco Clementi; Cecilia Gotti
An alpha4beta4 nicotinic receptor subtype is present in chick retina: identification, characterization and pharmacological comparison with the transfected alpha4beta4 and alpha6beta4 subtypes.
Molecular pharmacology 2001;59(6):1410-7.
2001: Cecilia Gotti; Milena Moretti; R Mantegazza; Diego Fornasari; T Tsouloufis; Francesco Clementi
Anti-neuronal nicotinic receptor antibodies in MG patients with thymoma.
Journal of neuroimmunology 2001;113(1):142-5.
2000: Ruud Zwart; Regina G D M Van Kleef; Cecilia Gotti; Chantal J G M Smulders; Henk P M Vijverberg
Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
Journal of neurochemistry 2000;75(6):2492-500.
2000: Carmen Martin-Ruiz; Margaret A Piggott; Cecilia Gotti; Jon Lindstrom; David Mendelow; M S Siddique; Robert H Perry; Elaine K Perry; Jennifer A Court
Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease.
Neuropharmacology 2000;39(13):2830-9.
2000: Cecilia Gotti; E Carbonnelle; Milena Moretti; Ruud Zwart; Francesco Clementi
Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Behavioural brain research 2000;113(1-2):183-92.
2000: B Balestra; Silvia Vailati; Milena Moretti; W Hanke; Francesco Clementi; Cecilia Gotti
Chick optic lobe contains a developmentally regulated alpha2alpha5beta2 nicotinic receptor subtype.
Molecular pharmacology 2000;58(2):300-11.
2000: Silvia Di Angelantonio; Andrea Nistri; M Moretti; Francesco Clementi; Cecilia Gotti
Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
British journal of pharmacology 2000;129(8):1771-9.
2000: Elaine K Perry; Carmen Martin-Ruiz; M Lee; M Griffiths; M Johnson; Margaret A Piggott; Vahram Haroutunian; Joseph Buxbaum; J Nãsland; Kenneth L Davis; Cecilia Gotti; Francesco Clementi; S Tzartos; O Cohen; H Soreq; Evelyn Jaros; Robert H Perry; Clive G Ballard; Ian G McKeith; Jennifer A Court
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
European journal of pharmacology 2000;393(1-3):215-22.
2000: Silvia Vailati; Milena Moretti; B Balestra; M McIntosh; Francesco Clementi; Cecilia Gotti
beta3 subunit is present in different nicotinic receptor subtypes in chick retina.
European journal of pharmacology 2000;393(1-3):23-30.
2000: Francesco Clementi; Diego Fornasari; Cecilia Gotti
Neuronal nicotinic receptors, important new players in brain function.
European journal of pharmacology 2000;393(1-3):3-10.
2000: ML Zaccaria; M Egle De Stefano; Cecilia Gotti; Tamara C Petrucci; Paola Paggi
Selective reduction in the nicotinic acetylcholine receptor and dystroglycan at the postsynaptic apparatus of mdx mouse superior cervical ganglion.
Journal of neuropathology and experimental neurology 2000;59(2):103-12.
2000: Francesco Clementi; Diego Fornasari; Cecilia Gotti
Neuronal nicotinic acetylcholine receptors: from structure to therapeutics.
Trends in pharmacological sciences 2000;21(2):35-37.
2000: B Balestra; Milena Moretti; Renato Longhi; R Mantegazza; Francesco Clementi; Cecilia Gotti
Antibodies against neuronal nicotinic receptor subtypes in neurological disorders.
Journal of neuroimmunology 2000;102(1):89-97.
1999: Carmen Martin-Ruiz; Jennifer A Court; E Molnar; M Lee; Cecilia Gotti; Avgi Mamalaki; T Tsouloufis; Socrates J Tzartos; Clive G Ballard; Robert H Perry; Elaine K Perry
Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
Journal of neurochemistry 1999;73(4):1635-40.
1999: Silvia Vailati; W Hanke; A Bejan; B Barabino; Renato Longhi; B Balestra; Milena Moretti; Francesco Clementi; Cecilia Gotti
Functional alpha6-containing nicotinic receptors are present in chick retina.
Molecular pharmacology 1999;56(1):11-9.
1999: L Maggi; Eleonora Palma; Fabrizio Eusebi; Milena Moretti; B Balestra; Francesco Clementi; Cecilia Gotti
Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
British journal of pharmacology 1999;126(1):285-95.
1998: Elena Battaglioli; Cecilia Gotti; S Terzano; Adriano Flora; Francesco Clementi; Diego Fornasari
Expression and transcriptional regulation of the human alpha3 neuronal nicotinic receptor subunit in T lymphocyte cell lines.
Journal of neurochemistry 1998;71(3):1261-70.
1998: ML Zaccaria; M Egle De Stefano; F Properzi; Cecilia Gotti; Tamara C Petrucci; Paola Paggi
Disassembly of the cholinergic postsynaptic apparatus induced by axotomy in mouse sympathetic neurons: the loss of dystrophin and beta-dystroglycan immunoreactivity precedes that of the acetylcholine receptor.
Journal of neuropathology and experimental neurology 1998;57(8):768-79.
1998: Cecilia Gotti; B Balestra; Milena Moretti; G Enrico Rovati; L Maggi; Giuseppe Rossoni; Ferruccio Berti; Luigi Villa; Marco Pallavicini; Francesco Clementi
4-Oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors.
British journal of pharmacology 1998;124(6):1197-206.
1997: Cecilia Gotti; Diego Fornasari; Francesco Clementi
Human neuronal nicotinic receptors.
Progress in neurobiology 1997;53(2):199-237.
1997: Cecilia Gotti; B Balestra; R Mantegazza; Socrates J Tzartos; Milena Moretti; Francesco Clementi
Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay.
Muscle & nerve 1997;20(7):800-8.
1997: Cecilia Gotti; Milena Moretti; Roberto Maggi; Renato Longhi; W Hanke; N Klinke; Francesco Clementi
Alpha7 and alpha8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties.
The European journal of neuroscience 1997;9(6):1201-11.
1995: Cecilia Gotti; Luca Briscini; Claudia Verderio; M Oortgiesen; B Balestra; Francesco Clementi
Native nicotinic acetylcholine receptors in human Imr32 neuroblastoma cells: functional, immunological and pharmacological properties.
The European journal of neuroscience 1995;7(10):2083-92.
1994: Cecilia Gotti; Milena Moretti; Renato Longhi; Luca Briscini; B Balestra; Francesco Clementi
Expression of alpha-bungarotoxin receptor subtypes in chick central nervous system during development.
Journal of receptor research 1994;14(6-8):335-46.
1994: Cecilia Gotti; W Hanke; K Maury; Milena Moretti; M Ballivet; Francesco Clementi; D Bertrand
Pharmacology and biophysical properties of alpha 7 and alpha 7-alpha 8 alpha-bungarotoxin receptor subtypes immunopurified from the chick optic lobe.
The European journal of neuroscience 1994;6(8):1281-91.
1993: Cecilia Gotti; Milena Moretti; Renato Longhi; Luca Briscini; E Manera; Francesco Clementi
Anti-peptide specific antibodies for the characterization of different alpha subunits of alpha-bungarotoxin binding acetylcholine receptors present in chick optic lobe.
Journal of receptor research 1993;13(1-4):453-65.
1992: Cecilia Gotti; W Hanke; Wolf-Rüdiger Schlue; Luca Briscini; Milena Moretti; Francesco Clementi
A functional alpha-bungarotoxin receptor is present in chick cerebellum: purification and characterization.
Neuroscience 1992;50(1):117-27.
1991: Cecilia Gotti; A E Ogando; W Hanke; R Schlue; Milena Moretti; Francesco Clementi
Purification and characterization of an alpha-bungarotoxin receptor that forms a functional nicotinic channel.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(8):3258-62.
1991: F Clementi; Cecilia Gotti; Emanuele Sher; A Zanini
Cell plasticity during in vitro differentiation of a human neuroblastoma cell line.
Advances in experimental medicine and biology 1991;296():91-102.
1989: Emanuele Sher; Cecilia Gotti; Nicola Canal; Ciriaco Scoppetta; G Piccolo; Amelia Evoli; Francesco Clementi
Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.
Lancet 1989;2(8664):640-3.
1989: Cecilia Gotti; A E Ogando; Francesco Clementi
The alpha-bungarotoxin receptor purified from a human neuroblastoma cell line: biochemical and immunological characterization.
Neuroscience 1989;32(3):759-67.
1988: Cecilia Gotti; Emanuele Sher; B Chini; Diego Fornasari; A Esparis Ogando; Francesco Clementi
The nicotinic receptors in the nervous system.
Pharmacological research communications 1988;20(8):637-62.
1988: Cecilia Gotti; F Frigerio; M Bolognesi; Renato Longhi; Gabriella Racchetti; Francesco Clementi
Nicotinic acetylcholine receptor: a structural model for alpha-subunit peptide 188-201, the putative binding site for cholinergic agents.
FEBS letters 1988;228(1):118-22.
1988: Francesco Clementi; Cecilia Gotti; Lucia Mori; Paola Ricciardi-Castagnoli
Suppressor T cells in myasthenia gravis.
Monographs in allergy 1988;25():41-9.
1988: Enzo Mancinelli; Cecilia Gotti; Emanuele Sher; Arnaldo Ferroni; Enzo Wanke
Receptor-activated ion channels in neuroblastoma cells.
Annals of the New York Academy of Sciences 1988;551():239-41.
1987: Cecilia Gotti; D Cabrini; Emanuele Sher; Francesco Clementi
Effects of long-term in vitro exposure to aluminum, cadmium or lead on differentiation and cholinergic receptor expression in a human neuroblastoma cell line.
Cell biology and toxicology 1987;3(4):431-40.
1987: Cecilia Gotti; G Mazzola; Renato Longhi; Diego Fornasari; Francesco Clementi
The binding site for alpha-bungarotoxin resides in the sequence 188-201 of the alpha-subunit of acetylcholine receptor: structure, conformation and binding characteristics of peptide [Lys] 188-201.
Neuroscience letters 1987;82(1):113-9.
1987: Francesco Clementi; D Cabrini; Cecilia Gotti; Diego Fornasari; Emanuele Sher
A human neuroblastoma cell line for neurotoxicity testing in vitro: effects of heavy metals.
Progress in clinical and biological research 1987;253():137-49.
1987: Francesco Clementi; F Sinigaglia; Lucia Mori; M Bozzi; Cecilia Gotti; Paola Ricciardi-Castagnoli
A suppressor T-cell line specific for the nicotinic cholinergic receptor.
Annals of the New York Academy of Sciences 1987;505():639-54.
1987: Cecilia Gotti; Emanuele Sher; D Cabrini; G Bondiolotti; Enzo Wanke; Enzo Mancinelli; Francesco Clementi
Cholinergic receptors, ion channels, neurotransmitter synthesis, and neurite outgrowth are independently regulated during the in vitro differentiation of a human neuroblastoma cell line.
Differentiation; research in biological diversity 1987;34(2):144-55.
1986: Francesco Clementi; D Cabrini; Cecilia Gotti; Emanuele Sher
Pharmacological characterization of cholinergic receptors in a human neuroblastoma cell line.
Journal of neurochemistry 1986;47(1):291-7.
1986: Cecilia Gotti; Enzo Wanke; Emanuele Sher; Diego Fornasari; D Cabrini; Francesco Clementi
Acetylcholine operated ion channel and alpha-bungarotoxin binding site in a human neuroblastoma cell line reside on different molecules.
Biochemical and biophysical research communications 1986;137(3):1141-7.
1984: Cecilia Gotti; R Mantegazza; F Clementi
New antigen for antibody detection in myasthenia gravis.
Neurology 1984;34(3):374-7.